Overview
Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis
Status:
Completed
Completed
Trial end date:
2016-09-22
2016-09-22
Target enrollment:
0
0
Participant gender:
All
All
Summary
The objective of this study was to evaluate the safety, efficacy, and pharmacokinetics of luliconazole cream 1% when applied topically for 7 days in pediatric participants 2 years to 17 years of age (inclusive) with tinea corporis.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.Treatments:
Luliconazole
Criteria
Key Inclusion Criteria:- Participants (or legal guardian/caregiver) with the ability and willingness to sign a
written informed consent and/or assent (age appropriate).
- Participants of either gender must be at least 2 years to less than (<) 18 years of
age (2 to 17 years, inclusive).
- Participants with a clinical diagnosis of tinea corporis characterized by clinical
evidence of a tinea infection (at least moderate erythema, mild scaling, and moderate
pruritus).
- Participants must be in good general health and free of any disease that in the
Investigator's opinion might interfere with the study evaluations.
- Participants/caregiver must be able to communicate, be able to understand the study
procedures, and be willing to comply with the study requirements.
Key Exclusion Criteria:
- Participants with active atopic or contact dermatitis in the area to be treated.
- Participants with severe dermatophytoses, mucocutaneous candidiasis, or bacterial skin
infection.
- Female participants who are pregnant and/or nursing or planning a pregnancy during the
course of the trial. Participants who test positive for pregnancy after start study
drug will be discontinued from study drug but will be followed for safety purposes.
- Participants who are immunocompromised (due to disease, for example; human
immunodeficiency virus [HIV] or medications).
- Participants who have a recent history of or current drug or alcohol abuse.